WebinarsNew
Explore Business Standard
Cosmetic products supplied in injectable form do not fall under the definition of cosmetics under the law and are not permitted for use by consumers, professionals or aesthetic clinics, the central drug regulator has made it clear. The advisory by the Central Drugs Standard Control Organisation's (CDSCO) comes amid the growing popularity of injectable aesthetic procedures being promoted as "cosmetic" treatments in beauty clinics and wellness centres across the country. The clarification is aimed at preventing misuse of cosmetic products for treatment purposes and ensuring consumer safety, particularly as non-surgical aesthetic procedures gain popularity in urban centres and through social media promotion, a source said. The move also seeks to curb misleading advertising and unauthorised cosmetic practices by clinics and individuals. In the public notice issued on May 18, the regulator said that cosmetics are intended only to be "rubbed, poured, sprinkled or sprayed" on the body fo
PEP Brands is targeting a 30-35 per cent growth in FY26, as digital appetite and online discovery fuel consumption of beauty and personal care labels in India, its co-founder and CEO Tarun Sharma said, adding, he is hopeful that the company will go public in the next 3-4 years. "We are dreamy-eyed founders, we would want to ring the bell," Sharma told PTI in an interview as he spoke about his vision for mCaffeine and Hyphen, the two brands of PEP. PEP Brands' flagship mCaffeine focuses mainly on bodycare products leveraging coffee-based ingredients, while its skincare label, in collaboration with actor Kriti Sanon, is Hyphen. Sanon is also co-founder of Hyphen. PEP aims to build businesses in a manner that it is a good listable story, Sharma said, adding that "an IPO is 3-4 years out". "India is a large market. There can be 5-6 good companies (pure-play DTCs or Direct-to-Consumer brands) getting listed. A good company means good to consumers, having some market share, financials ..